Pharmaceutical combinations comprising a pyrido [4, 3-d] pyrimidine derived Hsp90-inhibitor and a HER2 inhibitor

Details for Australian Patent Application No. 2009319050 (hide)

Owner Novartis AG

Inventors Garcia-Echeverria, Carlos; Jensen, Michael

Agent Davies Collison Cave

Pub. Number AU-A-2009319050

PCT Pub. Number WO2010/060939

Priority 08170261.5 28.11.08 EP; 08170255.7 28.11.08 EP

Filing date 25 November 2009

Wipo publication date 3 June 2010

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

16 June 2011 PCT application entered the National Phase

  PCT publication WO2010/060939 Priority application(s): WO2010/060939

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009319051-Hsp90 inhibitors for therapeutic treatment

2009319048-Pharmaceutical combination comprising a Hsp 90 inhibitor and a mTOR inhibitor